Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers. [electronic resource]
Producer: 20110725Description: 169-71 p. digitalISSN:- 1651-2057
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- C-Reactive Protein -- metabolism
- Drug Eruptions
- Female
- Hidradenitis Suppurativa -- blood
- Humans
- Infliximab
- Leukocyte Count
- Male
- Middle Aged
- Neutrophils -- metabolism
- Pain
- Quality of Life
- Retrospective Studies
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.